Picture of Mydecine Innovations logo

MYCO Mydecine Innovations Balance Sheet

0.000.00%
ca flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Mydecine Innovations, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

2018
December 31st
R2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash
Short Term Investments
Cash and Short Term Investments0.0110.0182.191.54.63
Net Total Accounts Receivable
Net Total Receivables0.2170.0120.0410.2050.363
Total Inventory
Prepaid Expenses
Total Current Assets0.4930.6012.55.226.21
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment4.620.0760.5150.5650.01
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets5.212.069.537.586.9
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities1.840.2075.82.955.8
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities1.840.2315.977.3710.5
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity3.361.833.560.211-3.6
Total Liabilities & Shareholders' Equity5.212.069.537.586.9
Total Common Shares Outstanding
0